A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood
Clinical trial NCT06504862 · COMPLETED
Trial details
- NCT number
- NCT06504862
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2024-10-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.